298 related articles for article (PubMed ID: 15688391)
1. HPV16 semiquantitative viral load and serologic biomarkers in oral and oropharyngeal squamous cell carcinomas.
Kreimer AR; Clifford GM; Snijders PJ; Castellsagué X; Meijer CJ; Pawlita M; Viscidi R; Herrero R; Franceschi S;
Int J Cancer; 2005 Jun; 115(2):329-32. PubMed ID: 15688391
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study.
Anantharaman D; Gheit T; Waterboer T; Abedi-Ardekani B; Carreira C; McKay-Chopin S; Gaborieau V; Marron M; Lagiou P; Ahrens W; Holcátová I; Merletti F; Kjaerheim K; Talamini R; Simonato L; Castellsague X; Macfarlane TV; Biggs AM; Thakker N; Znaor A; Thomson P; Canova C; Conway DI; Healy CM; Tommasino M; Pawlita M; Brennan P
J Natl Cancer Inst; 2013 Apr; 105(8):536-45. PubMed ID: 23503618
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma.
Holzinger D; Wichmann G; Baboci L; Michel A; Höfler D; Wiesenfarth M; Schroeder L; Boscolo-Rizzo P; Herold-Mende C; Dyckhoff G; Boehm A; Del Mistro A; Bosch FX; Dietz A; Pawlita M; Waterboer T
Int J Cancer; 2017 Jun; 140(12):2748-2757. PubMed ID: 28316084
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study.
Herrero R; Castellsagué X; Pawlita M; Lissowska J; Kee F; Balaram P; Rajkumar T; Sridhar H; Rose B; Pintos J; Fernández L; Idris A; Sánchez MJ; Nieto A; Talamini R; Tavani A; Bosch FX; Reidel U; Snijders PJ; Meijer CJ; Viscidi R; Muñoz N; Franceschi S;
J Natl Cancer Inst; 2003 Dec; 95(23):1772-83. PubMed ID: 14652239
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers of HPV in head and neck squamous cell carcinoma.
Liang C; Marsit CJ; McClean MD; Nelson HH; Christensen BC; Haddad RI; Clark JR; Wein RO; Grillone GA; Houseman EA; Halec G; Waterboer T; Pawlita M; Krane JF; Kelsey KT
Cancer Res; 2012 Oct; 72(19):5004-13. PubMed ID: 22991304
[TBL] [Abstract][Full Text] [Related]
6. Serum Antibodies to HPV16 Early Proteins Warrant Investigation as Potential Biomarkers for Risk Stratification and Recurrence of HPV-Associated Oropharyngeal Cancer.
Fakhry C; Qualliotine JR; Zhang Z; Agrawal N; Gaykalova DA; Bishop JA; Subramaniam RM; Koch WM; Chung CH; Eisele DW; Califano J; Viscidi RP
Cancer Prev Res (Phila); 2016 Feb; 9(2):135-41. PubMed ID: 26701665
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence.
Lang Kuhs KA; Kreimer AR; Trivedi S; Holzinger D; Pawlita M; Pfeiffer RM; Gibson SP; Schmitt NC; Hildesheim A; Waterboer T; Ferris RL
Cancer; 2017 Nov; 123(22):4382-4390. PubMed ID: 28950407
[TBL] [Abstract][Full Text] [Related]
8. From HPV-positive towards HPV-driven oropharyngeal squamous cell carcinomas.
Boscolo-Rizzo P; Pawlita M; Holzinger D
Cancer Treat Rev; 2016 Jan; 42():24-9. PubMed ID: 26547133
[TBL] [Abstract][Full Text] [Related]
9. HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients.
Castellsagué X; Alemany L; Quer M; Halec G; Quirós B; Tous S; Clavero O; Alòs L; Biegner T; Szafarowski T; Alejo M; Holzinger D; Cadena E; Claros E; Hall G; Laco J; Poljak M; Benevolo M; Kasamatsu E; Mehanna H; Ndiaye C; Guimerà N; Lloveras B; León X; Ruiz-Cabezas JC; Alvarado-Cabrero I; Kang CS; Oh JK; Garcia-Rojo M; Iljazovic E; Ajayi OF; Duarte F; Nessa A; Tinoco L; Duran-Padilla MA; Pirog EC; Viarheichyk H; Morales H; Costes V; Félix A; Germar MJ; Mena M; Ruacan A; Jain A; Mehrotra R; Goodman MT; Lombardi LE; Ferrera A; Malami S; Albanesi EI; Dabed P; Molina C; López-Revilla R; Mandys V; González ME; Velasco J; Bravo IG; Quint W; Pawlita M; Muñoz N; de Sanjosé S; Xavier Bosch F;
J Natl Cancer Inst; 2016 Jun; 108(6):djv403. PubMed ID: 26823521
[TBL] [Abstract][Full Text] [Related]
10. Biologic predictors of serologic responses to HPV in oropharyngeal cancer: The HOTSPOT study.
Anderson KS; Gerber JE; D'Souza G; Pai SI; Cheng JN; Alam R; Kesiraju S; Chowell D; Gross ND; Haddad R; Gillison ML; Posner M
Oral Oncol; 2015 Aug; 51(8):751-8. PubMed ID: 26094591
[TBL] [Abstract][Full Text] [Related]
11. Human Papillomavirus 16 E6 Antibodies in Individuals without Diagnosed Cancer: A Pooled Analysis.
Lang Kuhs KA; Anantharaman D; Waterboer T; Johansson M; Brennan P; Michel A; Willhauck-Fleckenstein M; Purdue MP; Holcátová I; Ahrens W; Lagiou P; Polesel J; Simonato L; Merletti F; Healy CM; Kjaerheim K; Conway DI; Macfarlane TV; Thomson P; Castellsagué X; Znaor A; Black A; Huang WY; Krogh V; Trichopoulou A; Bueno-de-Mesquita HB; Clavel-Chapelon F; Weiderpass E; Ekström J; Riboli E; Tjønneland A; Sánchez MJ; Travis RC; Hildesheim A; Pawlita M; Kreimer AR
Cancer Epidemiol Biomarkers Prev; 2015 Apr; 24(4):683-9. PubMed ID: 25623733
[TBL] [Abstract][Full Text] [Related]
12. Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials.
Jordan RC; Lingen MW; Perez-Ordonez B; He X; Pickard R; Koluder M; Jiang B; Wakely P; Xiao W; Gillison ML
Am J Surg Pathol; 2012 Jul; 36(7):945-54. PubMed ID: 22743284
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus seropositivity and risks of head and neck cancer.
Smith EM; Ritchie JM; Pawlita M; Rubenstein LM; Haugen TH; Turek LP; Hamsikova E
Int J Cancer; 2007 Feb; 120(4):825-32. PubMed ID: 17131312
[TBL] [Abstract][Full Text] [Related]
14. Viral RNA patterns and high viral load reliably define oropharynx carcinomas with active HPV16 involvement.
Holzinger D; Schmitt M; Dyckhoff G; Benner A; Pawlita M; Bosch FX
Cancer Res; 2012 Oct; 72(19):4993-5003. PubMed ID: 22991302
[TBL] [Abstract][Full Text] [Related]
15. HPV16 E6/E7 expression in circulating tumor cells in oropharyngeal squamous cell cancers: A pilot study.
Economopoulou P; Koutsodontis G; Avgeris M; Strati A; Kroupis C; Pateras I; Kirodimos E; Giotakis E; Kotsantis I; Maragoudakis P; Gorgoulis V; Scorilas A; Lianidou E; Psyrri A
PLoS One; 2019; 14(5):e0215984. PubMed ID: 31071126
[TBL] [Abstract][Full Text] [Related]
16. Antibodies against high-risk human papillomavirus proteins as markers for noncervical HPV-related cancers in a Black South African population, according to HIV status.
Singini MG; Muchengeti M; Sitas F; Chen WC; Combes JD; Waterboer T; Clifford GM
Int J Cancer; 2024 Jul; 155(2):251-260. PubMed ID: 38577820
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas.
Rietbergen MM; Snijders PJ; Beekzada D; Braakhuis BJ; Brink A; Heideman DA; Hesselink AT; Witte BI; Bloemena E; Baatenburg-De Jong RJ; Leemans CR; Brakenhoff RH
Int J Cancer; 2014 May; 134(10):2366-72. PubMed ID: 24249631
[TBL] [Abstract][Full Text] [Related]
18. Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas.
van Houten VM; Snijders PJ; van den Brekel MW; Kummer JA; Meijer CJ; van Leeuwen B; Denkers F; Smeele LE; Snow GB; Brakenhoff RH
Int J Cancer; 2001 Jul; 93(2):232-5. PubMed ID: 11410871
[TBL] [Abstract][Full Text] [Related]
19. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells.
Rampias T; Sasaki C; Weinberger P; Psyrri A
J Natl Cancer Inst; 2009 Mar; 101(6):412-23. PubMed ID: 19276448
[TBL] [Abstract][Full Text] [Related]
20. Markers of HPV infection and survival in patients with head and neck tumors.
Koslabova E; Hamsikova E; Salakova M; Klozar J; Foltynova E; Salkova E; Rotnaglova E; Ludvikova V; Tachezy R
Int J Cancer; 2013 Oct; 133(8):1832-9. PubMed ID: 23564321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
